Effect of astaxanthin on hepatocellular injury following ischemia/reperfusion

Toxicology

Volumn 267, Issue 1-3, 2010, Pages 147-153

  Curek, Gulten D ^a   Cort, Aysegul ^a   Yucel, Gultekin ^a   Demir, Necdet ^a   Ozturk, Saffet ^a   Elpek, Gulsum O ^a   Savas, Berna ^b   Aslan, Mutay ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

Author keywords

Astaxanthin; Ischemia reperfusion; Liver; Oxidative stress

Indexed keywords

ALANINE AMINOTRANSFERASE; ASTAXANTHIN; CAROTENOID; GLUTATHIONE; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRATE; NITRITE; OLIVE OIL; XANTHINE DEHYDROGENASE; XANTHINE OXIDASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTERY CLAMP; ARTERY OCCLUSION; ARTICLE; CELL DAMAGE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; DRUG MECHANISM; DRUG STRUCTURE; ENZYME ACTIVITY; HEART RIGHT VENTRICLE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIVER BLOOD FLOW; LIVER CELL; LIVER CELL DAMAGE; LIVER ISCHEMIA; LIVER PARENCHYMA; MALE; MITOCHONDRION SWELLING; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; ROUGH ENDOPLASMIC RETICULUM; SCORING SYSTEM; SPECTROSCOPY; STRUCTURE ACTIVITY RELATION; TISSUE LEVEL; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING;

ALANINE TRANSAMINASE; ANIMALS; ANTIOXIDANTS; DISEASE MODELS, ANIMAL; GLUTATHIONE; LIVER; MALE; NITRATES; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; PROTEIN CARBONYLATION; RATS; RATS, WISTAR; REPERFUSION INJURY; XANTHINE DEHYDROGENASE; XANTHINE OXIDASE; XANTHOPHYLLS;

ANIMALIA; RATTUS;

EID: 71849120171     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2009.11.003     Document Type: Article

References (43)

1. Adkison D., Höllwarth M.E., Benoit J.N., Parks D.A., McCord J.M., and Granger D.N. Role of free radicals in ischemia-reperfusion injury to the liver. Acta Physiol. Scand. Suppl. 548 (1986) 101-107
2. Aliciguzel Y., Ozen I., Aslan M., and Karayalcin U. Activities of xanthine oxidoreductase and antioxidant enzymes in different tissues of diabetic rats. J. Lab. Clin. Med. 142 (2003) 172-177
3. 2-dependent type. Amino acid sequence of rat liver xanthine dehydrogenase and identification of the cleavage sites of the enzyme protein during irreversible conversion by trypsin. J. Biol. Chem. 265 (1990) 14170-14175
4. Aslan M., and Canatan D. Modulation of redox pathways in neutrophils from sickle cell disease patients. Exp. Hematol. 36 (2008) 1535-1544
5. Aslan M., and Freeman B.A. Oxidases and oxygenases in regulation of vascular nitric oxide signaling and inflammatory responses. Immunol. Res. 26 (2002) 107-118
6. Aslan M., Ryan T.M., Adler B., Townes T.M., Parks D.A., Thompson J.A., Tousson A., Gladwin M.T., Patel R.P., Tarpey M.M., Batinic-Haberle I., White C.R., and Freeman B.A. Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 15215-15220
7. Aslan M., Ryan T.M., Townes T.M., Coward L., Kirk M.C., Barnes S., Alexander C.B., Rosenfeld S.S., and Freeman B.A. Nitric oxide-dependent generation of reactive species in sickle cell disease. Actin tyrosine induces defective cytoskeletal polymerization. J. Biol. Chem. 278 (2003) 4194-4204
8. Aslan M., Yücel I., Ciftçioǧlu A., Savaş B., Akar Y., Yücel G., and Sanlioglu S. Corneal protein nitration in experimental uveitis. Exp. Biol. Med. 232 (2007) 1308-1313
9. Aslan M., Yücel I., Akar Y., Yücel G., Ciftçioǧlu M.A., and Sanlioglu S. Nitrotyrosine formation and apoptosis in rat models of ocular injury. Free Radic. Res. 40 (2006) 147-153
10. Atalla S.L., Toledo-Pereyra L.H., MacKenzie G.H., and Cederna J.P. Influence of oxygen-derived free radical scavengers on ischemic livers. Transplantation 40 (1985) 584-590
11. Beckman J.S., Parks D.A., Pearson J.D., Marshall P.A., and Freeman B.A. A sensitive fluorometric assay for measuring xanthine dehydrogenase and oxidase in tissues. Free Radic. Biol. Med. 6 (1989) 607-615
12. Carden D.L., and Granger D.N. Pathophysiology of ischaemia-reperfusion injury. J. Pathol. 190 (2000) 255-266
13. Colletti L.M., Kunkel S.L., Walz A., Burdick M.D., Kunkel R.G., Wilke C.A., and Strieter R.M. The role of cytokine networks in the local liver injury following hepatic ischemia/reperfusion in the rat. Hepatology 23 (1996) 506-514
14. Drugas G.T., Paidas C.N., Yahanda A.M., Ferguson D., and Clemens M.G. Conjugated desferoxamine attenuates hepatic microvascular injury following ischemia/reperfusion. Circ. Shock 34 (1991) 278-283
15. Enroth C., Eger B.T., Okamoto K., Nishino T., Nishino T., and Pai E.F. Crystal structures of bovine milk xanthine dehydrogenase and xanthine oxidase: structure-based mechanism of conversion. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 10723-10728
16. Gross G.J., and Lockwood S.F. Cardioprotection and myocardial salvage by a disodium disuccinate astaxanthin derivative (Cardax). Life Sci. 75 (2004) 215-224
17. Gross G.J., and Lockwood S.F. Acute and chronic administration of disodium disuccinate astaxanthin (CardaxTM) produces marked cardioprotection in dog hearts. Mol. Cell. Biochem. 272 (2005) 221-227
18. Guerin M., Huntley M.E., and Olaizola M. Haematococcus astaxanthin: applications for human health and nutrition. Trends Biotechnol. 21 (2003) 210-216
19. Hasselgren P.O. Prevention and treatment of ischemia of the liver. Surg. Gynecol. Obstet. 164 (1987) 187-196
20. Isobe M., Katsuramaki T., Hirata K., Kimura H., Nagayama M., and Matsuno T. Beneficial effects of inducible nitric oxide synthase inhibitor on reperfusion injury in the pig liver. Transplantation 68 (1999) 803-813
21. Isobe M., Katsuramaki T., Kimura H., Nagayama M., Matsuno T., Yagihashi A., and Hirata K. Role of inducible nitric oxide synthase on hepatic ischemia and reperfusion injury. Transplant. Proc. 32 (2000) 1650-1652
22. Jaeschke H., Farhood A., and Smith C.W. Neutrophils contribute to ischemia/reperfusion injury in rat liver in vivo. FASEB J. 4 (1990) 3355-3359
23. Karaman A., Fadillioglu E., Turkmen E., Tas E., and Yilmaz Z. Protective effects of leflunomide against ischemia-reperfusion injury of the rat liver. Pediatr. Surg. Int. 22 (2006) 428-434
24. Kooij A., Schijns M., Frederiks W.M., Van Noorden C.J., and James J. Distribution of xanthine oxidoreductase activity in human tissues-a histochemical and biochemical study. Virchows Arch. B: Cell Pathol. Incl. Mol. Pathol. 63 (1992) 17-23
25. Kurashige M., Okimasu E., Inoue M., and Utsumi K. Inhibition of oxidative injury of biological membranes by astaxanthin. Physiol. Chem. Phys. Med. NMR 22 (1990) 27-38
26. Lee V.G., Johnson M.L., Baust J., Laubach V.E., Watkins S.C., and Billiar T.R. The roles of iNOS in liver ischemia-reperfusion injury. Shock 16 (2001) 355-360
27. Lemasters J.J., and Thurman R.G. Reperfusion injury after liver preservation for transplantation. Annu. Rev. Pharmacol. Toxicol. 37 (1997) 327-338
28. Lim B.P., Nagao A., Terao J., Tanaka K., Suzuki T., and Takama K. Antioxidant activity of xanthophylls on peroxyl radical-mediated phospholipid peroxidation. Biochim. Biophys. Acta 1126 (1992) 178-184
29. Marubayashi S., Dohi K., Ochi K., and Kawasaki T. Role of free radicals in ischemic rat liver cell injury: prevention of damage by alpha-tocopherol administration. Surgery 99 (1986) 184-192
30. McCord J.M. Oxygen-derived free radicals in postischemic tissue injury. N. Engl. J. Med. 312 (1985) 159-163
31. McKelvey T.G., Höllwarth M.E., Granger D.N., Engerson T.D., Landler U., and Jones H.P. Mechanisms of conversion of xanthine dehydrogenase to xanthine oxidase in ischemic rat liver and kidney. Am. J. Physiol. 254 (1988) G753-G760
32. Naguib Y.M. Antioxidant activities of astaxanthin and related carotenoids. J. Agric. Food Chem. 48 (2000) 1150-1154
33. Olthoff K.M. Can reperfusion injury of the liver be prevented? Trying to improve on a good thing. Pediatr. Transplant. 5 (2001) 390-393
34. Palozza P., and Krinsky N.I. Astaxanthin and canthaxanthin are potent antioxidants in a membrane model. Arch. Biochem. Biophys. 297 (1992) 291-295
35. Reznick A.Z., and Packer L. Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol. 233 (1994) 357-363
36. Shacter E. Protein oxidative damage. Methods Enzymol. 319 (2000) 428-436
37. Shibata A., Kiba Y., Akati N., Fukuzawa K., and Terada H. Molecular characteristics of astaxanthin and beta-carotene in the phospholipids monolayer and their distributions in the phospholipid bilayer. Chem. Phys. Lipids 113 (2001) 11-22
38. Showalter L.A., Weinman S.A., Østerlie M., and Lockwood S.F. Plasma appearance and tissue accumulation of non-esterified, free astaxanthin in C57BL/6 mice after oral dosing of a disodium disuccinate diester of astaxanthin (Heptax). Comp. Biochem. Physiol. C: Toxicol. Pharmacol. 137 (2004) 227-236
39. Stadtman E.R., and Oliver C.N. Metal-catalyzed oxidation of proteins. Physiological consequences. J. Biol. Chem. 266 (1991) 2005-2008
40. Weiss S.J. Tissue destruction by neutrophils. N. Engl. J. Med. 320 (1989) 365-376
41. Yilmaz S., Ates E., Tokyol C., Pehlivan T., Erkasap S., and Koken T. The protective effect of erythropoietin on ischaemia/reperfusion injury of liver. HPB 6 (2004) 169-173
42. Yücel I., Akar Y., Yücel G., Ciftçioǧlu M.A., Keleş N., and Aslan M. Effect of hypercholesterolemia on inducible nitric oxide synthase expression in a rat model of elevated intraocular pressure. Vision Res. 45 (2005) 1107-1114
43. Yücel I., Yücel G., Akar Y., Demir N., Gürbüz N., and Aslan M. Transmission electron microscopy and autofluorescence findings in the cornea of diabetic rats treated with aminoguanidine. Can. J. Ophthalmol. 41 (2006) 60-66